AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 24 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,463,000 | -9.0% | 2,979 | 0.0% | 0.19% | -30.4% |
| Q3 2021 | $2,707,000 | -65.9% | 2,979 | -62.6% | 0.28% | -62.4% |
| Q2 2021 | $7,929,000 | -49.7% | 7,969 | -47.5% | 0.74% | -52.4% |
| Q1 2021 | $15,768,000 | +33.8% | 15,192 | -99.9% | 1.54% | -4.1% |
| Q4 2020 | $11,781,000 | +265.8% | 12,710,000 | +217.8% | 1.61% | +130.1% |
| Q3 2020 | $3,221,000 | – | 4,000,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,100,000 | $8,937,000 | 3.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 174,372,000 | $170,826,000 | 3.40% |
| PFM Health Sciences, LP | 48,150,000 | $47,381,000 | 1.71% |
| DeepCurrents Investment Group LLC | 17,738,000 | $17,424,000 | 0.67% |
| Weiss Asset Management LP | 17,595,000 | $17,263,000 | 0.42% |
| DAFNA Capital Management LLC | 1,500,000 | $1,476,000 | 0.40% |
| Westchester Capital Management, LLC | 3,853,000 | $3,792,000 | 0.11% |
| Calamos Advisors LLC | 15,438,000 | $15,147,000 | 0.07% |
| Verition Fund Management LLC | 10,316,000 | $5,081,076 | 0.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,532,000 | $2,491,000 | 0.03% |